News Summary
NeutralGlobe Life reported strong Q2 2026 earnings with 20% net income growth and raised full-year guidance by $0.10 at midpoint to $15.55–$15.95, demonstrating consistent double-digit operating income growth. However, a major analyst downgrade despite improved results, combined with acknowledged expense pressures, regulatory scrutiny risks, and an earnings miss in the quarter, suggests execution concerns temper the positive fundamental momentum.
Red flags
- •Analyst downgrade despite raised guidance and earnings beat signals skepticism on expense profile and execution risks
- •Q2 earnings miss noted in narrative despite reported per-share growth
- •Ongoing DOJ and SEC investigations represent renewed regulatory risk despite 2025 investigation closures
- •Higher expense profile flagged as near-term risk by investment community
- •Regulatory scrutiny remains active watch item despite prior favorable resolutions
Funds Reducing / Exiting (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Maverick Capital | Lee Ainslie | 0 | −11K | — | <0.1% | -100% | EXITED |
| Soros Fund Management | Soros Family Office | 0 | −60K | — | 0.1% | -100% | EXITED |
| Point72 | Steve Cohen | 0 | −42K | — | <0.1% | -100% | EXITED |
Shares Held reflects quarter-end positions for partial reductions. Funds that fully exited show 0 shares held. ∆ Shares is the change from the prior quarter. % of Fund is the prior-quarter position size — how much of the book was sold down.
Insider Activity
| Name | Title | Type | Shares | Price | Value | Filed | Src |
|---|---|---|---|---|---|---|---|
| Hensley Robert Edward | EVP & Chief Investment Officer | SELL | 3K | $169.53 | $0.57M | 2026-09-22 | ↗ |
| Hensley Robert Edward | EVP & Chief Investment Officer | SELL | 7K | $170.34 | $1.13M | 2026-09-22 | ↗ |
| MITCHELL ROBERT BRIAN | EVP, General Counsel and CRO | SELL | 11K | $182.77 | $2.09M | 2026-08-07 | ↗ |
| MITCHELL ROBERT BRIAN | EVP, General Counsel and CRO | SELL | 11K | $183.83 | $1.94M | 2026-08-07 | ↗ |
| MITCHELL ROBERT BRIAN | EVP, General Counsel and CRO | SELL | 1K | $184.75 | $0.19M | 2026-08-07 | ↗ |
| Darden James Matthew | Co-Chairman & CEO | SELL | 50K | $182.43 | $9.05M | 2026-07-31 | ↗ |
| Darden James Matthew | Co-Chairman & CEO | SELL | 400 | $183.36 | $0.07M | 2026-07-31 | ↗ |
| Kalmbach Thomas Peter | EVP & CFO | SELL | 11K | $179.30 | $1.92M | 2026-07-30 | ↗ |
| Kalmbach Thomas Peter | EVP & CFO | SELL | 5K | $180.08 | $0.87M | 2026-07-30 | ↗ |
| Kalmbach Thomas Peter | EVP & CFO | SELL | 3K | $181.23 | $0.48M | 2026-07-30 | ↗ |
| Kalmbach Thomas Peter | EVP & CFO | SELL | 3K | $181.81 | $0.51M | 2026-07-30 | ↗ |
| MAJORS MICHAEL CLAY | EVP - Chief Strategy Officer | SELL | 34K | $178.56 | $5.98M | 2026-07-29 | ↗ |
| MAJORS MICHAEL CLAY | EVP - Chief Strategy Officer | SELL | 4K | $179.35 | $0.63M | 2026-07-29 | ↗ |
| Kalmbach Thomas Peter | EVP & CFO | SELL | 10K | $178.06 | $1.70M | 2026-07-28 | ↗ |
| Kalmbach Thomas Peter | EVP & CFO | SELL | 12K | $178.73 | $2.20M | 2026-07-28 | ↗ |
| Kalmbach Thomas Peter | EVP & CFO | SELL | 4K | $179.42 | $0.68M | 2026-07-28 | ↗ |
| Skarjune Dolores L | EVP and Chief Admin. Officer | SELL | 2K | $179.18 | $0.33M | 2026-06-30 | ↗ |
Beneficial Ownership (13D/13G)
| Filer | Form | Shares | % of Class | Filed | Src |
|---|---|---|---|---|---|
| Invesco Ltd. | SC 13G | 4.0M | 5.1% | 2026-05-06 | ↗ |
| Vanguard Capital Management | SC 13G | 5.8M | 7.5% | 2026-04-30 | ↗ |
| Vanguard Portfolio Management | SC 13G | 4.3M | 5.4% | 2026-04-29 | ↗ |
SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.
Congressional Trading
| Member | Chamber | State | Type | Amount Range | Transaction Date | Filed | Src |
|---|---|---|---|---|---|---|---|
| Alan Armstrong | senate | — | BUY | $1,001 - $15,000 | 2026-03-27 | 2026-07-21 | ↗ |
Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.